Article
Oncogenic PIK3CA mutations in lobular breast cancer progression.
Genes, chromosomes & cancer - 1 Jan 2013
Christgen Matthias, Noskowicz Monika, Schipper Elisa, Christgen Henriette, Heil Charlotte, Krech Till, Länger Florian, Kreipe Hans, Lehmann Ulrich
Abstract excerpt
Infiltrating lobular breast cancer (ILBC) is a tumor-biologically distinct breast cancer subtype. A high frequency of oncogenic PIK3CA mutations has been reported in ILBC, which may allow for targeted therapy with newly developed PI3K inhibitors. This is of particular clinical relevance for ILBC patients, who have failed to respond to current treatment regimes and suffer from tumor recurrence or dissemination. In...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
